Plastic Surgeons Group Calls for Delaying Gender‑Affirming Surgery Until Age 19

The American Society of Plastic Surgeons (ASPS), the largest professional body representing plastic surgeons in the United States, has recently issued a position urging clinicians to delay gender‑affirming surgeries for minors until they reach 19 years of age. This guidance includes surgical interventions such as chest reconstruction, genital procedures, and facial surgeries for transgender and nonbinary youth. According to ASPS, the recommendation is based on an evaluation of current scientific evidence, developmental considerations, and concerns regarding the long-term outcomes of these irreversible procedures. The organization noted that while gender‑affirming surgeries can provide significant psychological and social benefits for adults, the evidence supporting equivalent long-term benefits in minors remains insufficient and inconsistent. The guidance emphasizes a cautious approach, balancing compassion for adolescents experiencing gender dysphoria with the imperative to protect long-term health and well-being. The statement also references recent studies and governmental reports, including the Cass Review from the UK and a 2025 report by the U.S. Department of Health and Human Services, which collectively underscore that robust, longitudinal data on surgical outcomes in minors are limited. ASPS clarifies that this position is not a clinical mandate but rather an expert recommendation aimed at informing professional practice and encouraging careful deliberation. The organization highlighted that the decision to delay surgery considers not only physical and surgical risks but also psychosocial development, cognitive maturity, and the ability to provide informed consent, factors that are often still evolving in adolescents. In addition, ASPS cited ethical concerns related to the irreversible nature of surgical interventions and the potential for regret or adverse outcomes later in life, which, although uncommon, underscore the importance of evidence-informed guidance. By issuing this recommendation, the society aims to provide a framework for surgeons, healthcare providers, families, and policymakers to approach gender-affirming care with caution, scientific rigor, and ethical responsibility.

ASPS’s recommendation diverges from positions held by other professional medical associations, which have historically endorsed individualized, case-by-case approaches to gender-affirming care for adolescents. Organizations such as the American Academy of Pediatrics and the World Professional Association for Transgender Health (WPATH) advocate for collaborative decision-making involving clinicians, patients, and families, rather than strict age cutoffs. These groups emphasize comprehensive evaluation of mental health, social support, and developmental readiness, and typically support access to surgical and non-surgical interventions based on clinical judgment rather than chronological age alone. In contrast, ASPS emphasizes that a hard minimum age of 19 provides a safeguard against the uncertainties inherent in long-term surgical outcomes for minors. The society’s position highlights the ongoing tension between individualized care models and broader safety-oriented guidelines, reflecting both clinical uncertainties and evolving societal debates around transgender health. Additionally, the recommendation comes at a time of heightened political and regulatory scrutiny regarding gender-affirming care in the United States. Federal policy pressures and legal challenges have increasingly influenced hospital practices, with some institutions limiting or suspending services for transgender minors amid fears of litigation or regulatory non-compliance. ASPS’s stance has been interpreted by some policymakers and advocacy groups as aligning with efforts to prioritize patient safety while mitigating legal and ethical concerns. The guidance acknowledges that while surgeries are infrequent in minors, the stakes are significant, given that irreversible procedures carried out during adolescence intersect with ongoing psychological, cognitive, and physical development. By providing a clearly defined age threshold, ASPS aims to facilitate professional consistency, protect patients from potential harm, and offer a defensible rationale for surgical decision-making in a complex and politically sensitive environment.

The broader implications of ASPS’s guidance extend into ongoing debates about best practices in transgender healthcare, including the role of puberty blockers, hormone therapy, and comprehensive mental health support. Experts note that delaying surgery does not equate to withholding care, as non-surgical interventions can continue to support adolescents’ psychological well-being while providing time for physical maturity and informed decision-making. Nonetheless, the recommendation reinforces the need for multidisciplinary approaches that integrate endocrinology, psychiatry, social work, and surgical expertise to ensure holistic care. The guidance also underscores the importance of rigorous research on long-term surgical outcomes, including quality of life, psychological adjustment, and potential complications, to inform evidence-based policy in the future. Ethical considerations remain central to the discussion, with professional societies, clinicians, and advocacy organizations navigating complex questions about autonomy, consent, risk mitigation, and developmental capacity. ASPS stresses that safeguarding adolescents’ long-term welfare is paramount and that delaying irreversible surgical interventions provides time for careful evaluation, counseling, and exploration of individual needs. At the same time, clinicians are encouraged to continue providing supportive care, including mental health counseling and social support, to help patients navigate gender dysphoria during adolescence. The position highlights a nuanced balance between access to care and caution, reflecting both scientific uncertainty and the evolving nature of ethical standards in pediatric and adolescent medicine. In the context of ongoing debates, the recommendation represents a significant professional position with potential influence on clinical practice, policy discussions, and public perceptions of transgender healthcare in the United States.